Olmesartan Medoxomil/Hydrochlorothiazide Zydus (Olmesartan Medoxomil, Hydrochlorothiazide)

Olmesartan medoxil, the active ingredient in Olmesartan Medoxomil/Hydrochlorothiazide Zydus, is an angiotensin II receptor blocker presented as a tablet for oral use. It treats hypertension, often in combination with a diuretic, and is intended for adult patients. GNH USA supplies Olmesartan Medoxomil/Hydrochlorothiazide Zydus as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Olmesartan Medoxomil/Hydrochlorothiazide Zydus as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Olmesartan Medoxil/Hydrochlorothiazide is used primarily ​​     ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​

- Hypertension: Lowers blood pressure when used alone or with other antihypertensives. - Heart failure: Assists in fluid management as part of a broader therapeutic regimen. - Edema associated with renal or hepatic disease: Reduces excess fluid accumulation. - Post‑myocardial infarction care: Supports blood‑pressure control as part of secondary prevention. - Diabetic nephropathy: Helps mitigate hypertension‑related kidney damage. - High‑risk cardiovascular risk patients with multiple risk factors : Provides additional blood‑pressure reduction beyond monotherapy alone.

Common     …  … … ... ....  …  ...